New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Open Access
- 17 August 2007
- journal article
- Published by Springer Nature in EMBO Reports
- Vol. 8 (9) , 871-878
Abstract
The androgen receptor (AR) initiates important developmental and oncogenic transcriptional pathways. The AR is known to bind as a homodimer to 15‐base pair bipartite palindromic androgen‐response elements; however, few direct AR gene targets are known. To identify AR promoter targets, we used chromatin immunoprecipitation with on‐chip detection of genomic fragments. We identified 1,532 potential AR‐binding sites, including previously known AR gene targets. Many of the new AR target genes show altered expression in prostate cancer. Analysis of sequences underlying AR‐binding sites showed that more than 50% of AR‐binding sites did not contain the established 15 bp AR‐binding element. Unbiased sequence analysis showed 6‐bp motifs, which were significantly enriched and were bound directly by the AR in vitro. Binding sequences for the avian erythroblastosis virus E26 homologue (ETS) transcription factor family were also highly enriched, and we uncovered an interaction between the AR and ETS1 at a subset of AR promoter targets.Keywords
This publication has 25 references indexed in Scilit:
- Integrative molecular concept modeling of prostate cancer progressionNature Genetics, 2006
- Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse modelJournal of Molecular Endocrinology, 2005
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005
- MatInspector and beyond: promoter analysis based on transcription factor binding sitesBioinformatics, 2005
- Overexpression of Ets‐1 proto‐oncogene in latent and clinical prostatic carcinomasHistopathology, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9Journal of Biological Chemistry, 2003
- Androgen receptors in endocrine‐therapy‐resistant human prostate cancerInternational Journal of Cancer, 1991